StockData
AdaptHealth Corp. logo

AdaptHealth Corp. (AHCO) stock analysis

AHCONasdaqServices-Home Health Care ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3043% below fair value
$7.73+0.07 (+0.91%)

Close on Nov 16, 2026Market cap $1.05BP/E –Yield –

StockData Score

Prices as of Nov 16, 2026How the score works

Value3Growth0Performance0Health3Dividend0

Weak6 of 30 checks passed

AdaptHealth passes 6 of the 30 checks behind our score; 11 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
3/6
Growth
0/6
Past performance
0/6
Financial health
3/6
Dividend
0/6

What stands out

  • Margin of safety over 20%

    The price is 42.9% below fair value, more than the 20% cushion we look for.

  • Trading below fair value

    The share price of $7.73 is below our fair value estimate of $13.53.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 30.9% of total debt.

  • P/B below the industry

    AdaptHealth's price-to-book of 0.76 is below the Health Services median of 3.40.

What to watch

  • Return on equity under 15%

    Return on equity was -15.4% over the last twelve months and averaged -4.0% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was -3.4%, below the 10% that usually covers the cost of capital.

  • High debt

    Debt is 137% of shareholders' equity, above the 40% we consider low.

  • Revenue growing under 10% a year

    Revenue grew 3.0% a year over the last three fiscal years, short of the 10% we look for.

Valuation3/6
  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA above its 5-year median

    AdaptHealth's EV/EBITDA of 10.6 is above its 5-year median of 7.4.

  • P/B below the industry

    AdaptHealth's price-to-book of 0.76 is below the Health Services median of 3.40.

  • Trading below fair value

    The share price of $7.73 is below our fair value estimate of $13.53.

  • Margin of safety over 20%

    The price is 42.9% below fair value, more than the 20% cushion we look for.

Growth0/6
  • Revenue growing under 10% a year

    Revenue grew 3.0% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing slower than the industry

    Revenue grew 4.2% over the last twelve months; the Health Services median is 8.1%.

  • Guidance lowered

    AdaptHealth lowered its fiscal year 2026 Net revenue outlook on Aug 4, 2026.

  • Gross margin slipping

    Gross margin was 17.0% over the last twelve months, against 19.7% a year earlier.

Past performance0/6
  • Return on equity under 15%

    Return on equity was -15.4% over the last twelve months and averaged -4.0% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was -3.4%, below the 10% that usually covers the cost of capital.

  • Return on equity below the industry

    AdaptHealth's return on equity of -15.4% is below the Health Services median of 0.5%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin below its 5-year average

    Net margin was -7.1% over the last twelve months, against a 5-year average of -2.4%.

  • Net margin below the industry

    AdaptHealth's net margin of -7.1% is below the Health Services median of -3.9%.

Financial health3/6
  • High debt

    Debt is 137% of shareholders' equity, above the 40% we consider low.

  • Debt falling against equity

    Debt to equity fell from 221% five years ago to 137%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 30.9% of total debt.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term assets cover short-term debts

    Current assets are 1.12 times current liabilities.

  • Elevated bankruptcy risk

    The Altman Z-score is 0.62; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6
  • No dividend

    AdaptHealth has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Our estimate per share

$13.53

The share price is 43% below this estimate.

20%+ below
Near fair value
20%+ above
$7.73Price$13.53Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
EV/EBITDA11.1×7.4×14.9×$8.8458%
P/B2.1×0.9×3.4×$21.5317%
Earnings power7.7% cost of equity––$19.1425%
Fair value$13.53100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Health Services median 24.6

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Medium risk

Average value traded per day
$16.86M
Value traded per 1% price move
$6.88M

Downside

High risk

Typical loss in a bad month
48.4%
Volatility (annualized)
62%
Sharpe ratio, 1 year
-0.35
Beta to the S&P 500 (5Y)
-1.50

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2017 to 2025

Gross margin

18.8%+3.8 pts over 5 years

Operating margin

2.8%−4.0 pts over 5 years

Net margin

-2.2%+13.1 pts over 5 years

See a number that looks wrong?